Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
M.D. Anderson Cancer Center |
---|---|
Information provided by: | M.D. Anderson Cancer Center |
ClinicalTrials.gov Identifier: | NCT00813254 |
Primary Objective:
1. To longitudinally measure quality of life and sexual functioning and assess symptoms in women with recurrent, platinum-resistant ovarian cancer receiving multiple second-line treatment regimens
Secondary Objectives:
Condition | Intervention |
---|---|
Ovarian Cancer |
Behavioral: Questionnaire |
Study Type: | Observational |
Study Design: | Cohort, Retrospective |
Official Title: | Quality of Life and Cost Utility Analysis in the Treatment of Recurrent, Platinum-Resistant Ovarian Cancer |
Estimated Enrollment: | 41 |
Study Start Date: | December 2008 |
Estimated Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
Groups/Cohorts | Assigned Interventions |
---|---|
Patients with Ovarian Cancer that are platinum-resistant |
Behavioral: Questionnaire
Questionnaires 1 - 5 will be completed on Day 1 of study as a Baseline.
|
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Study participants that were diagnosed with Ovarian Cancer that are now "Platinum-Resistant."
Inclusion Criteria:
Exclusion Criteria:
Contact: Michael M Frumovitz, MD | 713-792-9599 |
United States, Texas | |
The University of Texas M.D. Anderson Cancer Center | Recruiting |
Houston, Texas, United States, 77030 |
Principal Investigator: | Michael M Frumovitz, MD | M.D. Anderson Cancer Center |
Responsible Party: | U.T.M.D. Anderson Cancer Center ( Michael M. Frumovitz, MD/Assistant Professor ) |
Study ID Numbers: | 2007-0611 |
Study First Received: | December 22, 2008 |
Last Updated: | June 22, 2009 |
ClinicalTrials.gov Identifier: | NCT00813254 History of Changes |
Health Authority: | United States: Institutional Review Board |
Platinum-Resistant Ovarian Cancer Platinum-based chemotherapy Ovarian Cancer Ovary Epithelial ovarian cancer |
Quality of Life Cost Utility Analysis Sexual functioning Questionnaire Caregiver |
Ovarian Neoplasms Gonadal Disorders Genital Neoplasms, Female Endocrine System Diseases Quality of Life Urogenital Neoplasms Ovarian Diseases |
Ovarian Epithelial Cancer Recurrence Genital Diseases, Female Ovarian Cancer Endocrinopathy Endocrine Gland Neoplasms |
Genital Diseases, Female Neoplasms Neoplasms by Site Ovarian Neoplasms Gonadal Disorders Genital Neoplasms, Female |
Endocrine System Diseases Urogenital Neoplasms Ovarian Diseases Adnexal Diseases Endocrine Gland Neoplasms |